Citation: Lr. Cantilena et Pk. Honig, QT DISPERSION AS A PREDICTOR OF PROARRHYTHMIA IN DRUG-INTERACTIONS WITH TERFENADINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 23-23
Authors:
KIEFFER LV
TAKIMOTO CH
MORRISON GB
CANTILENA LR
ALLEGRA CJ
GREM JL
MARINO M
Citation: Lv. Kieffer et al., DEVELOPMENT OF A PHARMACOKINETIC AND PHARMACODYNAMIC POPULATION-MODELOF PACLITAXEL ADMINISTERED WITH 5-FLUOROURACIL, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 69-69
Authors:
TAKIMOTO CH
DAHUT W
MARINO MT
NAKASHIMA H
LIANG MD
HAROLD N
LIEBERMAN R
ARBUCK SG
BAND RA
CHEN AP
HAMILTON JM
CANTILENA LR
ALLEGRA CJ
GREM JL
Citation: Ch. Takimoto et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF A 72-HOUR INFUSION OF 9-AMINOCAMPTOTHECIN IN ADULT CANCER-PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1492-1501
Authors:
GRAUMLICH JF
LUDDEN TM
CONRYCANTILENA C
CANTILENA LR
WANG YH
LEVINE M
Citation: Jf. Graumlich et al., PHARMACOKINETIC MODEL OF ASCORBIC-ACID IN HEALTHY MALE-VOLUNTEERS DURING DEPLETION AND REPLETION, Pharmaceutical research, 14(9), 1997, pp. 1133-1139
Authors:
SPYKER DA
HARVEY ED
HARVEY BE
HARVEY AM
RUMACK BH
PECK CC
ATKINSON AJ
WOOSLEY RL
ABERNETHY DR
CANTILENA LR
Citation: Da. Spyker et al., ASSESSMENT OF CLINICAL-PHARMACOLOGY INFORMATION (CPI) IN DRUG LABELING, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 4-4
Authors:
TAKIMOTO CH
LU ZH
ZHANG RW
LIANG MD
LARSON LV
CANTILENA LR
GREM JL
ALLEGRA CJ
DIASIO RB
CHU E
Citation: Ch. Takimoto et al., SEVERE NEUROTOXICITY FOLLOWING 5-FLUOROURACIL-BASED CHEMOTHERAPY IN APATIENT WITH DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY, Clinical cancer research, 2(3), 1996, pp. 477-481
Authors:
HONIG PK
WORTHAM DC
LAZAREV A
CANTILENA LR
Citation: Pk. Honig et al., GRAPEFRUIT JUICE ALTERS THE SYSTEMIC BIOAVAILABILITY AND CARDIAC REPOLARIZATION OF TERFENADINE IN POOR METABOLIZERS OF TERFENADINE, Journal of clinical pharmacology, 36(4), 1996, pp. 345-351
Authors:
LEVINE M
CONRYCANTILENA C
WANG YH
WELCH RW
WASHKO PW
DHARIWAL KR
PARK JB
LAZAREV A
GRAUMLICH JF
KING J
CANTILENA LR
Citation: M. Levine et al., VITAMIN-C PHARMACOKINETICS IN HEALTHY-VOLUNTEERS - EVIDENCE FOR A RECOMMENDED DIETARY ALLOWANCE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3704-3709
Citation: Lr. Cantilena et Rl. Woosley, SURVEY OF CLINICAL-PHARMACOLOGY TRAINING IN THE UNITED-STATES AND CANADA, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 1-7
Authors:
BENTON RE
HONIG PK
ZAMANI K
CANTILENA LR
WOOSLEY RL
Citation: Re. Benton et al., GRAPEFRUIT JUICE ALTERS TERFENADINE PHARMACOKINETICS RESULTING IN PROLONGATION OF REPOLARIZATION ON THE ELECTROCARDIOGRAM, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 383-388
Authors:
COYNE PE
AJAYI F
HARRIS J
WILEY T
WORTHAM D
CANTILENA LR
Citation: Pe. Coyne et al., ECG PHARMACODYNAMICS AND PHARMACOKINETICS OF HALOFANTRINE AND MEFLOQUINE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 7-7
Citation: Lr. Cantilena et Mj. Ratain, FOSTRIECIN NEPHROTOXICITY - AN IN-VITRO ASSESSMENT, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 8-8
Citation: Lr. Cantilena et Rl. Woosley, SURVEY OF CLINICAL-PHARMACOLOGY TRAINING IN NORTH-AMERICAN MEDICAL-SCHOOLS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 96-96
Citation: Cl. Ferguson et Lr. Cantilena, N-ACETYLCYSTEINE EFFECT ON MERCURY CLEARANCE DURING HEMODIALYSIS IN PIGS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 110-110
Citation: Ty. Kuang et Lr. Cantilena, EFFECT OF KETOCONAZOLE ON TERFENADINE ENANTIOMERIC METABOLISM IN HUMAN LIVER SLICES, MICROSOMES AND S9 FRACTIONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185
Citation: Ty. Kuang et Lr. Cantilena, TERFENADINE KETOCONAZOLE METABOLITE INTERACTION IN HUMAN LIVER-MICROSOMES OF MALE AND FEMALE SUBJECTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185
Citation: P. Honig et al., PHARMACOKINETICS AND CARDIAC EFFECTS OF TERFENADINE IN POOR METABOLIZERS RECEIVING CONCOMITANT GRAPEFRUIT JUICE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185
Citation: Lr. Cantilena et al., FLUCONAZOLE ALTERS TERFENADINE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PHARMACODYNAMICS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185
Citation: Da. Spyker et Lr. Cantilena, CARDIOVASCULAR AND CNS ADVERSE EVENTS FOR ANTIDEPRESSANTS REPORTED TOTHE FDA, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 190-190
Authors:
HOUGH DW
FERGUSON CL
WEINTRAUB M
CANTILENA LR
Citation: Dw. Hough et al., AN ASSESSMENT OF CRITERIA FOR INAPPROPRIATE PRESCRIBING OF PSYCHOTROPIC MEDICATIONS IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 199-199
Authors:
HONIG PK
WORTHAM DC
ZAMANI K
CANTILENA LR
Citation: Pk. Honig et al., COMPARISON OF THE EFFECT OF THE MACROLIDE ANTIBIOTICS ERYTHROMYCIN, CLARITHROMYCIN AND AZITHROMYCIN ON TERFENADINE STEADY-STATE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PARAMETERS, Drug investigation, 7(3), 1994, pp. 148-156
Citation: Ty. Kuang et al., COMPARISON OF HUMAN LIVER SLICES TO HUMAN LIVER-MICROSOMES AS POTENTIAL SCREENING SYSTEMS FOR TERFENADINE DRUG-INTERACTIONS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 138-138